126 related articles for article (PubMed ID: 17203175)
1. The expression of low density lipoprotein receptor-related protein in colorectal carcinoma.
Obermeyer K; Krueger S; Peters B; Falkenberg B; Roessner A; Röcken C
Oncol Rep; 2007 Feb; 17(2):361-7. PubMed ID: 17203175
[TBL] [Abstract][Full Text] [Related]
2. Human thyroid carcinoma cell invasion is controlled by the low density lipoprotein receptor-related protein-mediated clearance of urokinase plasminogen activator.
Sid B; Dedieu S; Delorme N; Sartelet H; Rath GM; Bellon G; Martiny L
Int J Biochem Cell Biol; 2006; 38(10):1729-40. PubMed ID: 16807059
[TBL] [Abstract][Full Text] [Related]
3. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
[TBL] [Abstract][Full Text] [Related]
4. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
[TBL] [Abstract][Full Text] [Related]
6. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?
Camani C; Gavin O; Kruithof EK
Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of both the low-density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression.
de Vries TJ; Verheijen JH; de Bart AC; Weidle UH; Ruiter DJ; van Muijen GN
Cancer Res; 1996 Mar; 56(6):1432-9. PubMed ID: 8640836
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas.
Yamamoto M; Ikeda K; Ohshima K; Tsugu H; Kimura H; Tomonaga M
Cancer Res; 1997 Jul; 57(13):2799-805. PubMed ID: 9205092
[TBL] [Abstract][Full Text] [Related]
9. u-PA expression in benign, borderline and malignant ovarian tumors.
Kiziridou AD; Toliou T; Stefanou D; Agnantis N
Anticancer Res; 2002; 22(2A):985-90. PubMed ID: 12014682
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
Talieri M; Papadopoulou S; Scorilas A; Xynopoulos D; Arnogianaki N; Plataniotis G; Yotis J; Agnanti N
Cancer Lett; 2004 Mar; 205(1):97-106. PubMed ID: 15036666
[TBL] [Abstract][Full Text] [Related]
11. Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression.
Berney CR; Yang J; Fisher RJ; Russell PJ; Crowe PJ
Oncol Res; 1998; 10(1):47-54. PubMed ID: 9613457
[TBL] [Abstract][Full Text] [Related]
12. Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.
Skelly MM; Troy A; Duffy MJ; Mulcahy HE; Duggan C; Connell TG; O'Donoghue DP; Sheahan K
Clin Cancer Res; 1997 Oct; 3(10):1837-40. PubMed ID: 9815571
[TBL] [Abstract][Full Text] [Related]
13. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
14. Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.
Castelló R; Landete JM; España F; Vázquez C; Fuster C; Almenar SM; Ramón LA; Radtke KP; Estellés A
Thromb Res; 2007; 120(5):753-62. PubMed ID: 17258797
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.
Levy EM; Bianchini M; Von Euw EM; Barrio MM; Bravo AI; Furman D; Domenichini E; Macagno C; Pinsky V; Zucchini C; Valvassori L; Mordoh J
Int J Oncol; 2008 Mar; 32(3):633-41. PubMed ID: 18292941
[TBL] [Abstract][Full Text] [Related]
16. Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression.
Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Lönnroth C; Lundholm K
Acta Oncol; 2007; 46(8):1107-12. PubMed ID: 17943472
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of expression of urokinase-type plasminogen activator in patients with prostate cancer.
Ohta S; Fuse H; Fujiuchi Y; Nagakawa O; Furuya Y
Anticancer Res; 2003; 23(3C):2945-50. PubMed ID: 12926141
[TBL] [Abstract][Full Text] [Related]
18. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin D protein levels in colorectal tumors: divergent expression patterns suggest complex regulation and function.
Iacobuzio-Donahue C; Shuja S; Cai J; Peng P; Willett J; Murnane MJ
Int J Oncol; 2004 Mar; 24(3):473-85. PubMed ID: 14767531
[TBL] [Abstract][Full Text] [Related]
20. Expression of the lung resistance protein in primary colorectal carcinomas.
Pohl G; Suchomel RW; Stranzl T; Depisch D; Stiglbauer W; Filipits M; Pirker R
Anticancer Res; 2001; 21(1A):201-4. PubMed ID: 11299735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]